Ultrafiltration rate as a dose surrogate in pre-dilution hemofiltration

International Journal of Artificial Organs

Volumn 30, Issue 2, 2007, Pages 124-132

  Huang, Zhongping ^a   Letteri, J J ^b   Clark, W R ^b,c   Zhang, W ^d   Gao, D ^e,f   Ronco, C ^g  

^a WIDENER UNIVERSITY   (United States)

^b Gambro Renal Products   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e University of Washington   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

^g SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Dilution; Dose; Hemofiltration; Solute; Ultrafiltration

Indexed keywords

PATIENT MONITORING; PATIENT TREATMENT; POLYSACCHARIDES; ULTRAFILTRATION; UREA;

COEFFICIENT VALUES; CRITICALLY-ILL PATIENTS; DOSE; F VALUES; HEMOFILTERS; HEMOFILTRATION; SIEVING COEFFICIENT; SOLUTE; TREATMENT EFFICIENCY; VANCOMYCIN;

MOLECULES;

CREATININE; INULIN; UREA; VANCOMYCIN;

ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG CLEARANCE; HEMOFILTRATION; HUMAN; INDICATOR DILUTION CURVE; KIDNEY DISEASE; MOLECULAR WEIGHT; PARAMETERS OF MEASUREMENT AND ANALYSIS; SOLUTE; ULTRAFILTRATION;

EID: 34147129239     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000207     Document Type: Article

References (42)

1. Henderson LW, Besarab A, Michaels AS, Bluemle LW. Blood purification by ultrafiltration and fluid replacement (diafiltration). Trans Am Soc Artif Intern Organs 1967; 13: 216-26.
2. Baldamus CA, Ernst W, Frei U, Koch KM. Sympathetic and hemodynamic response to volume removal during different forms of renal replacement therapy. Nephron 1982; 31: 324-32.
3. Colton CK, Henderson LW, Ford C, Lysaght MJ. Kinetics of hemodiafiltration. I. In vitro transport characteristics of a hollow-fiber blood ultrafilter. J Lab Clin Med 1975; 85: 355-71.
4. Ronco C, Bellomo R: Continuous renal replacement therapy: Evaluation in technology and current nomenclature. Kidney Int 1998; 53 (suppl 66): S160-4.
5. Macias WL, Mueller BA, Scarim SK, Robinson M, DW Rudy. Continuous veno-venous hemofiltration: An alternative to continuous arteriovenous hemofiltration and hemo-diafiltration in acute renal failure. Am J Kidney Dis 1991; 18: 451-8.
6. Clark, WR, Ronco C. Continuous renal replacement techniques. Contrib Nephrol 2004; 144: 264-77.
7. Clark WR, Ronco C. Renal replacement therapy in acute renal failure: Solute removal mechanisms and dose quantification. Kidney Int 1998; 53 (suppl 66): S133-7.
8. Bellomo R, Ronco C. Continuous versus intermittent renal replacement therapy in the intensive care unit. Kidney Int 1998; 53 (suppl 66): S125-8.
9. Clark WR, Mueller BA, Kraus MA, Macias WL. Dialysis prescription and kinetics in acute renal failure. Adv Ren Replace Ther 1997; 4: 64-71.
10. Clark WR, Mueller BA, Alaka KJ, Macias WL. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 1994; 4: 1413-20.
11. Clark WR, Mueller BA, Kraus MA, Macias WL. Solute control by extracorporeal therapies in acute renal failure. Am J Kidney Dis 1996; 28 (suppl 3): S21-7.
12. Clark WR, Mueller BA, Kraus MA, Macias WL. Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol 1997; 8: 804-12.
13. Liao Z, Zhang W, Poh CK, Huang Z, Hardy PA, Kraus MA, Clark WR, Gao D. Kinetic comparison of different acute dialysis therapies. Artif Organs 2003; 27: 802-7.
14. Mehta RL, Letteri JM. Current status of renal replacement therapy for acute renal failure. A survey of US nephrologists. The National Kidney Foundation Council on Dialysis. Am J Nephrol 1999; 19: 377-82.
15. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure. A prospective randomised trial. Lancet 2000; 356: 26-30.
16. Tetta C, Bellomo R, Kellum J, et al. High volume hemofiltration in critically ill patients: Why, when, and how? Contrib Nephrol 2004; 144: 362-75.
17. Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000; 28: 3581-7.
18. Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S, Zamparetti N, Brendolan A, D'Intini V, Tetta C, Bellomo R, Ronco C. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006; 32: 80-6.
19. Page B, Viellard-Baron A, Chergui K, et al. Early venovenous haemofiltration for sepsis-related multiple organ failure. Crit Care 2005; 9: R755-63.
20. Clark WR, Ronco C. CRRT efficiency and efficacy in relation to solute size. Kidney Int 1999; 56 (suppl 72): S3-S7.
21. Henderson LW. Pre vs post dilution hemofiltration. Clin Nephrol 1979; 11: 120-4.
22. Henderson LW. Biophysics of ultrafiltration and hemofiltration. In: Jucobs C, ed. Replacement of renal function by dialysis (4th ed). Dortdrecht: Kluwer Academic Publishers, 1996; 114-45.
23. Huang Z, Henderson LW, Gao D, Clark WR. Hemofiltration and hemodiafiltration for end-stage renal disease. In: Chronic kidney disease: Dialysis and transplantation. Amsterdam, The Netherlands: Elsevier Saunders; 2004 p. 481-90.
24. Bellomo R, Ronco R: Continuous renal replacement therapy in the intensive care unit. Intensive Care Med 1999; 25: 781-9.
25. Troyanov S, Cardinal J, Geadah D, et al. Solute clearances during continuous venvenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters. Nephrol Dial Transplant 2003; 18: 961-6.
26. Clark WR, Turk JE, Kraus MA, Gao D. Dose determinants in continuous renal replacement therapy. Artif Organs 2003; 27: 815-20.
27. Ahuja A, Rodby R, Huang Z, Gao D, Zhang W, Clark WR. Effect of pre-dilution replacement fluid administration on solute clearance in high-volume hemofiltration (Abstract). J Am Soc Nephrol 2003; 14: 734A.
28. Ledebo I. Principles and practice of hemofiltration and hemodiafiltration. Artif Organs 1998; 22: 20-5.
29. Scott MK, Mueller BA, Clark WR. Dialyzer-dependent changes in solute and water permeability with bleach reprocessing. Am J Kidney Dis 1999; 33: 87-96.
30. Henderson LW, Colton CK, Ford CA, Lysaght MJ. Kinetics of hemodiafiltration. II. Clinical characterization of a new blood cleansing modality. J Lab Clin Med 1975; 85: 372-91.
31. Kim S. Characteristics of protein removal in hemodiafiltration. Contrib Nephrol 1994; 108: 23-37.
32. Clark WR, Hamburger RJ, Lysaght MJ. Effect of membrane composition and structure on performance and biocompatibility in hemodialysis. Kidney Int 1999; 56: 2005-15.
33. Zhang W, Huang Z, Ahuja A, Rodby R, Clark WR, Gao D. Blood flow rate effects in high-dose pre-dilution CVVH (Abstract). J Am Soc Nephrol 2003; 14: 742A.
34. Rockel A, Hertel J, Fiegel P, Abdelhamid S, Panitz N, Walb D. Permeability and secondary membrane formation of a high flux polysufone hemofilter. Kidney Int 1986; 30: 429-32.
35. Clark WR, Macias WL, Molitoris BA, Wang NHL. Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 1995; 48: 481-7.
36. Ofsthun NJ, Zydney AL. Importance of convection in artificial kidney treatment. Contrib Nephrol 1994; 108: 53-70.
37. Langsdorf LJ, Zydney AL. Effect of blood contact on the transport properties of hemodialysis membranes: A two-layer model. Blood Purif 1994; 12: 292-307.
38. Morti SM, Zydney AL. Protein-membrane interactions during hemodialysis: Effects on solute transport. ASAIO J 1998; 44: 319-26.
39. Ofsthun NJ, Colton CK, Lysaght MJ. Determinants of fluid and solute removal rates during hemofiltration. In: Henderson LW, Quellhorst EA, Baldamus CA, Lysaght MJ, eds. Hemofiltration. Berlin: Springer-Verlag, 1986; 18-39.
40. Pedrini LA, De Cristafaro V. On-line mixed hemodiafiltration with a feedback for ultrafiltration control: Effect on middle-molecule removal. Kidney Int 2003; 64: 1505-13.
41. Canaud B, Levesque R, Krieter D, et al. On-line hemodiafiltration as routine treatment of end-stage renal failure: Why pre- or mixed dilution mode is necessary in on-line hemodiafiltration today? Blood Purif 2004; 22 (suppl 2): S40-8.
42. Salvatori, G, Ricci Z, Bonello M, et al. First clinical trial for a new CRRT machine: The Prismaflex. Int J Artif Organs. 2004; 27: 404-9.